CAS RN: 1255095-03-4
tert-Butyl (2-broMo-4-Methylthiazol-5-yl)carbaMate
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20251213 |
100mg / 250mg / 1g |
Out of stock |
5-7 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g, 5g, 10g
- Available purity: >97%
- Inventory rows with stock: 5
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1255095-03-4
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>97% |
1
In Stock
|
Shenzhen |
Inquiry |
| 0.25g |
>97% |
1
In Stock
|
Shenzhen |
Inquiry |
| 1g |
>97% |
1
In Stock
|
Hong Kong |
Inquiry |
| 5g |
>97% |
1
In Stock
|
Beijing |
Inquiry |
| 10g |
>97% |
1
In Stock
|
Shanghai |
Inquiry |
1255095-03-4 / tert-butyl N-(2-bromo-4-methyl-1,3-thiazol-5-yl)carbamate
Standard CAS: 1255095-03-4
Multi CAS: No
Basic Information
CAS
1255095-03-4
Multi CAS
No
Molecular Formula
C9H13BrN2O2S
Molecular Weight
293.180000
Exact Mass
291.988110
SMILES
CC1=C(SC(=N1)Br)NC(=O)OC(C)(C)C
InChI
InChI=1S/C9H13BrN2O2S/c1-5-6(15-7(10)11-5)12-8(13)14-9(2,3)4/h1-4H3,(H,12,13)
InChIKey
RIFFGJWKHWQFCV-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
15
Aromatic heavy atom count
5
Fraction Csp3
0.56
Rotatable bonds
1
H-bond acceptors
4
H-bond donors
1
Molar refractivity
64.41
TPSA
51.22
LogP / Solubility
WLOGP
3.56
MLOGP
3.14
XLogP3
3.3
Consensus LogP
3.33
Log S (ESOL)
-4.08
Class (ESOL)
Slightly soluble
Log S (Ali)
-4.54
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.64
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-1.98
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5